Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc ACHFF


Primary Symbol: V.ARCH

Technology Scientific & Technical Instruments
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok... see more

Bullboard (TSXV:ARCH)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by Riverfolkon Dec 30, 2021 8:34pm

Arch Biopartners - My Due Diligence (NEW)

Arch Biopartners Inc. is a clinical stage company focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact.  Arch is ...more  
138
Discussion
Post by Riverfolkon Dec 30, 2021 8:31pm

ARCH - Minister Copping

“The drug candidate from Arch Biopartners, which has the generic name LSALT peptide, was discovered by @UCalgary scientists about five years ago.” https://twitter.com/JasonCoppingAB/status ...more  
101
Post by Riverfolkon Dec 30, 2021 8:25pm

ARCH - Premier Kenney

Great to see this made-in-Alberta COVID-19 drug move ahead to national human trial. Once again, Alberta is flexing its research and innovation muscle! https://twitter.com/jkenney/status ...more  
106
Post by Riverfolkon Dec 30, 2021 8:22pm

ARCH - The Honourable Navdeep Bains

“As the world works toward an effective COVID-19 vaccine, we cannot lose sight of the importance of developing treatments to keep those stricken with the virus alive. Today’s contribution will support ...more  
96
Post by Riverfolkon Dec 30, 2021 8:21pm

Arch - The Honourable Franois-Philippe Champagne

“Our support for Arch Biopartners’ development of their COVID-19 treatment is an important part of our plan to rebuild Canada’s bio-manufacturing and life sciences sector. Today’s ...more  
89
Post by TheBearInTheWoodson Dec 30, 2021 7:43pm

Here is the reason AGN is .04

You can buy there main drug candidate over the counter in Japan lmao  https://bio-japan.net/Ifenprodil-10mg-tablets
113
Discussion
Comment by C10H12N2on Dec 30, 2021 6:14pm

RE:$3.35- Extremely Undervalued in Comparison to Phase II peers

I find it hilariously hypocritical that you would place Bellus Health in comparison to Arch and Arch is not chasing Chronic Cough. Yet an actual company with Chronic Cough in it's portfolio at ...more  
81
Discussion
Comment by stocksarefunon Dec 30, 2021 5:37pm

RE:Todays House Positions

So.. net -80k shares for anonymous today alone. Endless shares???
43
Discussion
Post by Riverfolkon Dec 30, 2021 5:06pm

MetaBlok - A Pathway to an unmet 20 billion market

Recently Arch Biopartners released a glimpse of the human data waiting on publication from a third party, that should be expected shortly. This data was further validated by CATCO when they sponored a ...more  
119
Post by Riverfolkon Dec 30, 2021 5:04pm

$3.35- Extremely Undervalued in Comparison to Phase II peers

lets not forget that we are extremely undervalued compared to our Phase II peer group . REMEMBER THAT WE ARE NOW A PHASE III COMPANY Current market cap 162 mil US, we are 1.38 ...more  
144
Discussion
Post by Riverfolkon Dec 30, 2021 4:25pm

Todays House Positions

House Positions for C:ARCH from 20211230 to 20211230 House Bought $Val Ave Sold $Val Ave Net $Net ...more  
122
Discussion
Comment by stocksarefunon Dec 30, 2021 3:06pm

RE:RE:RE:Daily Manipulation Continues

I'll be watching closely for this report tomorrow 
63
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities